PharmaShots | Incisive News in 3 Shots

Subscribe Now

Multiple Cancer

Apobiologix's Bambevi (biosimilar- bevacizumab) Receives Health Canada Approval for Multiple Cancer Indications

Apobiologix's Bambevi (biosimilar- bevacizumab) Receives Health Canada Approval for Multiple Cancer Indications

September 27, 2021

CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications

CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications

October 29, 2020

Centus Biotherapeutics' Equidacent (bevacizumab- biosimilar) Receives CHMP's Positive Opinion for the Treatment of Multiple Cancer Indications

Centus Biotherapeutics' Equidacent (bevacizumab- biosimilar) Receives CHMP's Positive Opinion for the Treatment of Multiple Cancer...

July 27, 2020

Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications

March 12, 2020

Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and COVID-19

Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and...

March 6, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us